Financial results - DEPOMED EXIMPHARM SRL

Financial Summary - Depomed Eximpharm Srl
Unique identification code: 26573672
Registration number: J35/320/2010
Nace: 4773
Sales - Ron
301.243
Net Profit - Ron
-1.810
Employee
3
The most important financial indicators for the company Depomed Eximpharm Srl - Unique Identification Number 26573672: sales in 2023 was 301.243 euro, registering a net profit of -1.810 euro and having an average number of 3 employees. Firma isi desfasoara activitatea in domeniul Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Depomed Eximpharm Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 2.459.915 283.726 244.540 207.746 162.895 188.428 246.271 246.981 349.382 301.243
Total Income - EUR 2.465.808 346.570 252.368 1.109.096 173.958 188.866 248.384 247.136 349.523 301.688
Total Expenses - EUR 2.668.210 344.744 309.830 1.192.995 167.312 197.657 245.781 243.947 316.133 300.634
Gross Profit/Loss - EUR -202.403 1.825 -57.462 -83.899 6.647 -8.791 2.603 3.189 33.390 1.055
Net Profit/Loss - EUR -206.310 -8.243 -61.422 -85.535 5.073 -10.679 119 767 29.933 -1.810
Employees 8 4 2 3 3 3 3 3 3 3
Tabelul prezinta cei mai importanti indicatori ai firmei din Contul de Profit si Pierderi pentru ultimii 10 ani de activitate asa cum se regasesc la Ministerul de Finante. Datele ofera evolutia firmei in aceasta perioada privind cresterile si eventual descresterile inregistrate. In the last year of activity, the sales decreased by -13.5%, from 349.382 euro in the year 2022, to 301.243 euro in 2023. The Net Profit decreased by -29.842 euro, from 29.933 euro in 2022, to 0 in the last year.

Check the financial reports for the company - Depomed Eximpharm Srl

Rating financiar

Financial Rating -
Depomed Eximpharm Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Depomed Eximpharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Depomed Eximpharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Depomed Eximpharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Depomed Eximpharm Srl - CUI 26573672

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 1.464.324 1.164.434 1.166.913 7.752 5.845 4.325 3.216 2.139 1.138 12.841
Current Assets 761.722 506.348 348.388 184.839 211.162 176.719 198.705 159.471 189.563 176.152
Inventories 17.471 14.636 15.248 18.692 22.221 21.675 29.957 26.326 27.206 46.398
Receivables 737.598 484.244 310.056 132.995 138.700 132.356 107.833 23.338 76.647 36.921
Cash 6.654 7.469 23.083 33.152 50.241 22.688 60.914 109.807 85.710 92.833
Shareholders Funds 1.081.649 537.095 470.195 155.296 157.519 143.789 141.182 115.570 92.411 61.367
Social Capital 94 47 47 46 45 44 43 42 43 42
Debts 1.143.101 1.134.448 1.045.545 37.314 59.568 37.554 60.812 46.164 98.407 128.193
Income in Advance 1.424 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 176.152 euro in 2023 which includes Inventories of 46.398 euro, Receivables of 36.921 euro and cash availability of 92.833 euro.
The company's Equity was valued at 61.367 euro, while total Liabilities amounted to 128.193 euro. Equity decreased by -30.763 euro, from 92.411 euro in 2022, to 61.367 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Depomed Eximpharm Srl

Comments - Depomed Eximpharm Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.